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Abstract
Hypermutation of the immunoglobulin (Ig) genes requires Activation Induced cytidine Deaminase (AID) and transcription,
but it remains unclear why other transcribed genes of B cells do not mutate. We describe a reporter transgene crippled by
hypermutation when inserted into or near the Ig light chain (IgL) locus of the DT40 B cell line yet stably expressed when
inserted into other chromosomal positions. Step-wise deletions of the IgL locus revealed that a sequence extending for 9.8
kilobases downstream of the IgL transcription start site confers the hypermutation activity. This sequence, named DIVAC for
diversification activator, efficiently activates hypermutation when inserted at non-Ig loci. The results significantly extend
previously reported findings on AID-mediated gene diversification. They show by both deletion and insertion analyses that
cis-acting sequences predispose neighboring transcription units to hypermutation.
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Introduction
Vertebrate B cells are able to diversify their rearranged
immunoglobulin (Ig) genes by hypermutation, gene conversion and
class switch recombination. All three phenomena require expres-
sion of Activation Induced cytidine Deaminase (AID, NC_006088)
[1–3] which most likely initiates Ig gene diversification by
deaminating cytidines within the mutating and recombining
sequences [4,5]. A further requisite for hypermutation and switch
recombination is the transcription of the Ig genes and the switch
regions respectively [6,7].
Sequence analysis of transcribed non-Ig genes from AID
expressing B cells revealed either no or only a low number of
mutations compared to Ig genes [8]. A recent study of a large
number of expressed genes in B cells found a significantly higher
number of mutations in wild-type mice than in AID knock-out
mice [9]. However, the mutation rates for the non-Ig genes in AID
expressing B cells were still orders of magnitude lower than for the
Ig genes. To explain this difference between Ig and non-Ig genes it
has been postulated that cis-acting sequences in the Ig loci activate
hypermutation possibly by recruiting AID. However, intense
efforts did not succeed to unambiguously define these sequences
for the murine and human Ig loci [10]. Whereas studies using
chimeric reporter genes in transgenic mice indicated that certain Ig
enhancers and their surrounding sequences conferred hypermuta-
tion activity [11–14], deletion of Igk enhancers in knock-out mice
did not prevent hypermutation of the Igk gene (CAA36032)
[15,16]. At least one murine B cell line [17] and AID expressing
fibroblasts [18] mutated transcribed transgenes in the absence of
nearby Ig locus sequences, further confounding the issue of
whether cis-acting regulatory sequences are needed for hypermu-
tation.
The chicken B cell line DT40 diversifies its rearranged Ig light
chain (IgL) gene by gene conversion in the presence of nearby
pseudo V (yV) genes [2] and by hypermutation, if the yV genes
are deleted [19]. Both activities strictly depend on the
expression of AID. Consistent with the idea that the absence
of homologous gene conversion donors leads to hypermutation,
a Green Fluorescent Protein (GFP, AAB08058) transgene is rapidly
diversified by mutations when inserted into the rearranged IgL
locus [20]. The hypermutation activity of DT40 appeared
however to be limited to the IgL locus, because no mutations
were found in the highly transcribed Elongation Factor 1 alpha
gene (NP_989488) [19]. This was confirmed by a recent study
showing that neither the VpreB3 (NC_006102) nor the Carbonic
Anhydrase (XP_415218) gene, immediate upstream and down-
stream neighbors of the IgL locus respectively, showed sequence
heterogeneity in DT40 [21].
DT40 has been proposed as a model to study the mechanism of
Ig hypermutation [19]. Compared to mice and humans, the
chicken IgL locus including the yV genes is compact spanning only
30 kb. Furthermore, targeted integration of transfected DNA
constructs in DT40 allows the introduction of deletions and
insertions at defined chromosomal positions. Encouraged by these
advantages we decided to search for the elusive cis-acting
hypermutation control sequence in the IgL locus of DT40.
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A Hypermutation Reporter Based on GFP Expression
We have previously demonstrated that a GFP transgene in
DT40 rapidly accumulates mutations, when integrated at the
position of the promoter of the rearranged IgL locus [20]. The
hypermutation activity depended on AID expression and could be
visualized by the appearance of cells displaying decreased green
fluorescence due to detrimental GFP mutations. To exploit this
phenomenon, we designed a new expression cassette named GFP2
which consisted of the strong RSV promoter followed by the GFP
coding region, an internal ribosome entry site (IRES), the blasticidin
resistance gene (P19997) and the SV40 polyadenylation signal. GFP2
was incorporated into the targeting construct pIgL
GFP2 (Figure 1A)
in the opposite transcriptional orientation of the IgL gene to
minimize interference between transcriptional and post-transcrip-
tional regulation of the GFP2 transgene and the IgL gene.
Transfection of pIgL
GFP2 into the conditionally AID expressing
clone AID
R2 yielded a number of transfectants named IgL
GFP2 in
which targeted integration had substituted the IgL promoter by the
GFP2 transgene. Fluorescence activated cell sorting (FACS)
analysis of subclones from two independent primary transfectants
revealed median values of 12.8% and 14.5% decreased green
fluorescence two weeks after subcloning (Figure 1C and 1D). The
result confirms our previous study indicating that the GFP2
transgene is mutated at high rate within the rearranged IgL locus
and that cell populations with decreased green fluorescence can be
used to quantify this hypermutation activity.
Hypermutation in the Vicinity of the IgL Locus
Targeted integration was used to insert the GFP2 reporter at
various distances from the IgL locus into chromosome 15 [22]
(Figure 1B and Figure S1A). FACS analysis of primary
transfectants (Figure 1C and Table S1) and their subclones
(Figure 1D) revealed that the medians of decreased green
fluorescence fell to about 3% at the +26 kb and the 215 kb
positions, to 0.5% at the +52 kb position and to about 0.05% at
the 2135 kb position. The medians of decreased green
fluorescence were only around 0.001% at the +52, +26 and
2135 kb positions in the absence of AID (Figure 1C and 1D and
Table S1), indicating that the decreased green fluorescence was
dependent on AID expression.
Although we did not determine for the GFP2 insertions outside
the IgL locus, whether the rearranged or the unrearranged allele
was targeted, the results were representative for a large number of
independent primary transfectants (Table S1). Thus, hypermuta-
tion of the GFP2 reporter was detectable at insertions up to 52 kb
away from the IgL locus, but mutations declined with increasing
distance and were barely detectable at the 2135 kb position.
Since surrounding sequences were unlikely to influence the post-
transcriptional processing and translation of GFP2 transcripts,
GFP2 transcription should be reflected by the green fluorescence of
the cells independent of the transgene insertion site. Even in the
case of mutating transgenes, GFP2 transcription levels could be
deduced from the average green fluorescence of the major cell
populations which most likely expressed the un-mutated GFP
sequence. As seen by FACS analysis, the average green
fluorescence of the major cell populations varied slightly among
the primary transfectants (Figure 1C) most likely reflecting
chromosomal position effects. However, the transfectants
+52IgL
GFP2 and IgL
GFP2 differed more than 20 fold in their
median fluorescence decreases despite similar green fluorescence
of their major cell populations. This strongly suggested that the
hypermutation differences among the transfectants reflected the
distance of the GFP2 insertion sites to the IgL locus and not
variation in GFP2 transcription.
Identification of a Diversification Activator
The results could be explained by the presence of a cis-acting
sequence which activated hypermutation in a distance dependent
manner. We have named this putative regulatory sequence
Diversification Activator (DIVAC) and attempted to map it by
combining insertions of the GFP2 reporter with deletions of the IgL
locus.
To address the role of the yV part of the IgL locus, a GFP2
construct (Figure 2A, upper part) was transfected into the clone
yV
2AID
R1 [20] in which the entire 20 kb containing the yV
genes had been deleted. The transfectants yV
2IgL
GFP2 expressed
the GFP2 reporter at the position of the IgL promoter in the
absence of the yV locus.
FACS analysis of yV
2IgL
GFP2 primary transfectants showed
sizable populations of cells showing decreased green fluorescence
(Figure 2B) indicating that the GFP gene is diversified by
hypermutation. To rule out that the decrease of green fluorescence
is caused by gene silencing, the populations of high (GFP-high) and
low (GFP-low) green fluorescence were sorted from one of the
yV
2IgL
GFP2 primary transfectants (Figure 2C, left), and GFP
mRNA levels was analyzed by semi-quantitative reverse transcrip-
tion polymerase chain reaction (RT-PCR), (Figure 2C, right). RT-
PCR of the EF1a mRNA served as a control. Although GFP-low
cells showed on average more than 100-fold lower green
fluorescence than GFP-high cells, the levels of GFP mRNA were
comparable between sorted GFP-low, GFP-high and non-sorted
cells, confirming that the decrease of green fluorescence is not due
to silencing of GFP gene expression.
FACS analysis of yV
2IgL
GFP2 subclones revealed medians of
5.2% and 7.5% decreased green fluorescence (Figure 2D), only
one fold lower than the medians of the yV positive IgL
GFP2
subclones. As the difference between IgL
GFP2 and yV
2IgL
GFP2
subclones could be due to fluctuation effects or different AID
expression levels in the AID
R2 and yV
2AID
R1 precursors, the yV
locus seems to exert little, if any stimulation on the hypermutation
activity of the GFP2 reporter.
Author Summary
It remains an open question how AID-mediated gene
diversification is targeted to the immunoglobulin loci. Here
we define a cis-acting sequence, named DIVAC for
diversification activator, which is required for hypermuta-
tion of the Ig light chain gene and sufficient to activate
hypermutation at various non-Ig loci in the DT40 B cell line.
DIVAC is composed of multiple interacting sequences and
able to work over considerable distances both upstream
and downstream of its target gene. This work provides the
first conclusive evidence that AID-mediated gene diversi-
fication is targeted to the Ig loci by cis-acting sequences.
The conservation of AID-mediated Ig gene diversification
during vertebrate evolution suggests that DIVACs also play
a role in gene conversion, hypermutation, and switch
recombination in mammalian B cells. The findings should
be of general interest not only for molecular immunology
and the pathogenesis of B cell lymphomas but also the
whole field of biology as a unique example of how locus-
specific gene diversification is controlled. The described
experimental system offers unique advantages to further
clarify the molecular mechanism of DIVAC.
Control of Immunoglobulin Hypermutation
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2IgL
GFP2 still contained a 9.8 kb fragment of the rearranged
IgL locus extending from the IgL transcription start site until the 39
end of the carbonic anhydrase gene and referred to in the
following as fragment ‘W’. To test the relevance of this fragment, a
GFP2 construct was transfected into the clone yV
2IgL
2 in which
the entire rearranged IgL locus had been replaced by the puromycin
resistance gene (P42670). The resulting transfectants yV
2IgL
2,GFP2
had the puromycin resistance gene replaced by the GFP2 reporter at
the position of the deleted IgL locus (Figure 2A, middle part, and
Figure 2B). Subclones of yV
2IgL
2,GFP2 showed medians of only
0.01% and 0.02% decreased green fluorescence (Figure 2D), more
than 100 fold lower than the medians of yV
2IgL
GFP2 subclones.
This indicated that the ‘W’ fragment, absent in yV
2IgL
2,GFP2 but
present in yV
2IgL
GFP2, was required for hypermutation of the
GFP2 transgene. yV
2IgL
2 cells were then transfected by a
construct including the GFP2 transgene and the ‘W’ fragment
(Figure 2A, lower part). Subclones of the transfectants
yV
2IgL
W,GFP2 showed median green fluorescence decreases
similar to the medians of yV
2IgL
GFP2 subclones (Figure 2D).
Thus, the ‘W’ fragment efficiently activates hypermutation after
reinsertion into the IgL locus as expected for a true DIVAC
sequence.
Controls confirmed that the appearance of cells with decreased
green fluorescence reflected hypermutation in the GFP2 gene. As
expected, the decrease of green fluorescence in yV
2IgL
GFP2
cultures depended on AID, because subclones of the AID negative
transfectant yV
2IgL
GFP2AID
2/2 showed only very low medians
of 0.001% decreased green fluorescence (Figure 2D). Furthermore,
723 bp of the GFP open reading frame amplified from
yV
2IgL
GFP2 cells six weeks after subcloning showed an average
of 0.9 nucleotide substitutions per sequence (Figure 2E). As the
doubling time of the DT40 cell line is about 10 hours, the
mutation rate of the GFP gene of yV
2IgL
GFP2 was calculated to
be 1.3610
25 mutation/bp/generation, which was similar to the
mutation rate of the human hypermutating RAMOS cell line
(2.2610
25 mutation/bp/generation) [23,24]. The most prevalent
mutations were C to G and G to C transversions as previously
observed for hypermutation of the IgL VJ segments from yV
deleted DT40 clones [19]. In contrast, only a very low number of
nucleotide substitutions, most likely reflecting polymerase chain
reaction (PCR) artifacts, were found in the GFP gene of
yV
2IgL
2,GFP2 cells (Figure 2E).
Fine Mapping of DIVAC
A new series of targeting constructs was transfected into
yV
2IgL
2 to characterize the ‘W’ fragment by step-wise deletions
(Figure 3A). FACS analysis of subclones from the different
transfectants showed a variable but progressive loss of hypermuta-
tion activity when the ‘W’ fragment was shortened from either end
(Figure 3C). The 4 kb ‘S’ fragment in the middle of the ‘W’
fragment, which included the previously identified IgL enhancer
[25], still produced median green fluorescence decreases of 2.7%
and 1.7%. In contrast, the upstream ‘B’ and the downstream ‘P’
fragments on their own produced median green fluorescence
decreases of 0.13% and 0.05% respectively, which are low in
absolute terms, but clearly above the medians of yV
2IgL
2,GFP2.I f
either one of these fragments was combined with the ‘S’ fragment
in the ‘F’ and ‘K’ fragments respectively, the median decreases of
green fluorescence were elevated about 3 times. This suggested
that the DIVAC of the chicken IgL locus consisted of a central core
region and partially redundant flanking regions which contributed
to the overall activity. Clearly, more detailed analysis is needed to
define the location, the nature and the configuration of the active
motifs within the IgL DIVAC.
The average green fluorescence in the main population of
yV
2IgL
W,GFP2 was increased compared to yV
2IgL
2,GFP2
(Figure 2B) perhaps due to the additional stimulation of the RSV
promoter in GFP2 by the IgL enhancer of the ‘W’ fragment.
However, the relatively small decrease of GFP2 transcription seen in
yV
2IgL
2,GFP2 was unlikely to be responsible for the more than 300
fold reduction of hypermutation. Analysis of the ‘W’ fragment
deletions also strongly argued against the possibility that differences
in hypermutation were caused by alterations of GFP2 transcription
since primary transfectants of all fragments shown in Figure 3B
showed similar GFP transcription levels. Similar levels of steady-
state GFP2 transcripts were confirmed by RT-PCR (Figure S2).
Hypermutation at non-Ig Loci
To confirm that the GFP2 reporter on its own is stably expressed
at non-Ig loci, six loci on five different chromosomes [22] were
targeted by transfection of GFP2 constructs into yV
2AID
R1
(Figure 4A and Figure S1B). Neither the primary transfectants
(Figure 4B and Table S1B) nor their subclones (Figure 4C) showed
high percentages of decreased green fluorescence. Depending on
the experiment and the insertion site, the medians of the subclones
ranged from 0.02% to 0.22% indicating that the mutation rates of
the GFP2 reporter at the chosen loci were 50 to 500 fold lower than
at the IgL locus. However, these medians were about 2–10 fold
higher than the medians of various subclones from AID negative
transfectants (Figures 2D and 5C) confirming a slight increase in the
background mutation rates in AID expressing B cells [9].
GFP2 was then inserted together with the ‘W’ fragment into the
respective AID, BACH2 (NC_006090) and RDM1 (BAC02561) loci
of yV
2AID
R1 (Figure 5A and 5B). Subclones of the transfectants
yV
2AID
W,GFP2, yV
2BACH2
W,GFP2 and yV
2RDM1
W,GFP2
showed high median decreases of green fluorescence between
4.0% and 9.4% (Figure 5C) similar to the medians for
yV
2IgL
GFP2 and yV
2IgL
W,GFP2 subclones. GFP2 hypermutation
was AID dependent, since subclones of the AID negative
transfectants yV
2AID
W,GFP2/2, yV
2BACH2
W,GFP2/2AID
2/2
and yV
2RDM1
W,GFP2/2AID
2/2 showed very low medians of
decreased green fluorescence in the range of 0.001% to 0.03%.
These results demonstrated that the ‘W’ fragment was able to
activate AID mediated hypermutation at loci which otherwise did
not support hypermutation.
Discussion
We have identified a cis-acting sequence that is needed for
hypermutation at the chicken IgL locus and able to activate
hypermutation at other loci upon insertion. The 9.8 kb sequence,
named DIVAC for diversification activator, extends from the IgL
transcription start site towards the next downstream gene. DIVAC
seems to be composed of multiple interacting regions. Whereas a 4
Figure 1. Hypermutation of the GFP2 reporter at various distances from the rearranged IgL locus. (A) A physical map of the rearranged
IgL locus, a targeting construct including the GFP2 reporter and the IgL locus after targeted insertion of the GFP2 reporter. (B) Locations of GFP2
insertion relative to the IgL locus on chromosome 15. The reference point is the insertion site of GFP2 in the IgL
GFP2 transfectant. (C) FACS analysis of
primary transfectants having integrated the transfected construct targeted. (D) Fluctuation analysis of subclones. Each dot represents the analysis of a
single subclone and the median of all subclones from the same primary transfectant is indicated by a bar.
doi:10.1371/journal.pgen.1000332.g001
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hypermutation more than 100 fold above background level, the
flanking regions possess less activity on their own, but stimulate
hypermutation when combined with the core. Surprisingly, DIVAC
can act on either side of the hypermutation reporter and over long
distances.
Given the conservation of AID mediated Ig gene diversification
during vertebrate evolution, the identification of the chicken IgL
DIVAC should also be of relevance for mammals. Searches for cis-
acting hypermutation regulatory sequences in transgenic mice
showed that regions surrounding the Ig enhancers conferred
hypermutation activity [11–14]. Intriguingly, the location and
functional characteristics of these regions appear to be similar to
the core of the chicken IgL DIVAC. In hindsight, the difficulty to
unambiguously prove the existence of hypermutation activator
sequences may relate to the large size of the murine Ig loci and the
fact that DIVACs seem to be composed of multiple interacting
regions. As each of the murine Ig loci possesses at least two
enhancers at different positions, murine DIVACs may be composed
of multiple discontinuous sequences.
Bursal B cells and DT40 in the presence of nearby yV genes
diversify their rearranged IgL loci by gene conversion, suggesting
that one of the physiological roles of the IgL DIVAC is activation of
gene conversion. This is supported by a recent publication
showing that a deletion of the rearranged IgL locus downstream
of the C region stopped IgL gene diversification in yV positive
DT40 [26]. It seems also likely that DIVACs play a role for switch
recombination which is accompanied by hypermutation of the
recombining switch regions [27]. Possibly a dedicated DIVAC near
the switch regions activates switch recombination. As the chicken
IgL DIVAC can activate hypermutation in both directions over
large distances, it is also conceivable that a single DIVAC in the
heavy chain loci regulates both hypermutation and switch
recombination.
The mechanism of how a cis-regulatory sequence can activate
hypermutation in neighboring transcription units remains specu-
lative. Intriguingly, the chicken IgL DIVAC not only includes the
IgL enhancer, but also seems to act like an enhancer by activating
hypermutation over long distances in upstream or downstream
target genes. A plausible hypothesis may be that DIVAC promotes
the formation of protein complexes which first bind AID and then
hand it over to the neighboring transcription initiation complex.
Candidates for proteins involved in building such an AID docking
station would be DNA binding factors which recognize sequence
motifs within DIVAC. The described experimental system offers
unique advantages to test this hypothesis.
Materials and Methods
Targeting Constructs
The GFP2 construct was made by combining the RSV
promoter-GFP open reading frame of pHypermut2 [20] with a
PCR amplicon including an IRES [19], the blasticidin resistance gene
and the SV40 polyadenylation signal [28]. PCR was performed
using the primers described in the Table S2. GFP2 was flanked by
unique BamHI restriction sites for easy cloning into the targeting
vectors.
All targeting constructs except the ones belonging to the series of
‘W’ fragment deletions and reconstitutions were made by cloning
the arms sequences into pBluescriptKS+ (Stratagene, CA) and then
inserting GFP2 either into unique BamHI or BglII sites as shown in
Figure 5A and Figure S1. Targeting of AID [28] and RDM1 [29]
have been previously described. PCR amplifications of all target
arms were performed using the Expand long template PCR
System (Roche, Switzerland), DT40 genomic DNA as template
and primers as described in the Table S2.
Since the ‘W’ fragment was difficult to amplify as a single
sequence, it was sequentially cloned by combining upstream and
downstream PCR amplicons with a 2.2 kb AvrII/SpeI restriction
fragment excised from the rearranged IgL targeting construct
‘Construct R’ [30]. The sequence of the AvrII/SpeI restriction
fragment is A/T rich and localized between the J segment and the
C region. The assembled ‘W’ fragment of 9784 nucleotides was
sequenced and deposited into Genbank under the accession
number FJ482234. It starts at position 27 relative to the first base
of the IgL start codon and corresponds to the chicken genome
coordinates chr15:8165070–8176699 but lacks the VJ intervening
sequence.
Constructs belonging to ‘W’ fragment deletion series were made
by cloning GFP2 between the target arms and then inserting the
‘W’ fragment or parts thereof into unique NheI/SpeI sites. A BamHI
fragment containing GFP2 and the ‘W’ fragment was incorporated
into the AID, BACH2 and RDM1 targeting vectors to test the
activity of the ‘W’ fragment in non-Ig loci.
Cell Culture
Cells were cultured in chicken medium (RPMI-1640 or
DMEM/F-12 with 10% fetal bovine serum, 1% chicken serum,
2 mM L-glutamine, 0.1 mM b-mercaptoethanol and penicillin/
streptomycin) at 41uC with 5% CO2. Transfections were
performed by electroporation, using 40 mg of linearized plasmid
DNA with a Gene Pulser Xcell (BIO-RAD) at 25 mF and 700 V.
Stable transfectants were selected by culturing in 15 mg/ml of
blasticidin. Transfectants having integrated the transgenic con-
structs by targeted integration were identified by PCR using an
inside primer from the SV40 polyadenylation signal sequence of
GFP2 together with a primer derived from the sequence outside
the target arm (Table S2). In case of insertions into the IgL locus,
targeted integration into the rearranged allele was verified by
amplifying the VJ intervening sequence of the unrearranged locus.
The AID reconstituted clone AID
R2 was generated from the AID
deleted clone AID
2/2 [2] by transfection of a construct which
targeted an AID cDNA expression cassette into one of the deleted
AID loci. The AID negative transfectants were produced by
transfecting AID
2/2 and yV
2AID
2/2 [19], respectively.
Flow Cytometry
The phenotype of each mutation was determined by FACS
analysis of at least two independent targeted transfectants and
Figure 2. GFP2 hypermutation after deletion and reconstitution of the rearranged IgL locus. (A) Design of deletions and insertions in the
rearranged IgL locus using GFP2 targeting constructs. Upper part: Physical maps of the rearranged IgL locus after the deletion of the yV locus, a
targeting construct including the GFP2 reporter and the locus after targeted integration. Middle part: Physical maps of the deleted rearranged IgL
locus, a targeting construct including the GFP2 reporter and the GFP2 insertion site after targeted integration. Lower part: Physical maps of the
deleted rearranged IgL locus, a targeting construct including the GFP2 reporter together with the ‘W’ fragment and the locus after targeted
integration. (B) FACS analysis of primary transfectants. (C) Sorting of GFP-high and GFP-low cells from a yV
2IgL
GFP2 primary transfectant, and semi-
quantitative RT-PCR of GFP and EF1a messages from sorted and non-sorted cells. (D) Fluctuation analysis of subclones. (E) The frequencies of
particular nucleotide substitutions within the GFP open reading frame of GFP2.
doi:10.1371/journal.pgen.1000332.g002
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PLoS Genetics | www.plosgenetics.org 6 January 2009 | Volume 5 | Issue 1 | e1000332Figure 3. Analysis of the ‘W’ fragment deletion series. (A) A physical map of the deleted IgL locus and the aligned targeting constructs leading
to the insertion of the GFP2 reporter together with parts of the ‘W’ fragment. (B) FACS analysis of representative primary transfectants. (C) Fluctuation
analysis of subclones. Only the letter of the reconstituted fragment and not the full name of the transfectants is indicated for clarity.
doi:10.1371/journal.pgen.1000332.g003
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PLoS Genetics | www.plosgenetics.org 7 January 2009 | Volume 5 | Issue 1 | e1000332Figure 4. Insertions of the GFP2 reporter into non-Ig loci. (A) Chromosomal locations of the GFP2 insertions. (B) FACS analysis of primary
transfectants. (C) Fluctuation analysis of subclones.
doi:10.1371/journal.pgen.1000332.g004
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PLoS Genetics | www.plosgenetics.org 8 January 2009 | Volume 5 | Issue 1 | e1000332Figure 5. Hypermutation of the GFP2 reporter at non-Ig loci in the presence of the ‘W’ fragment. (A) Physical maps of the non-Ig loci, the
targeting constructs including the GFP2 reporter together with the ‘W’ fragment and the loci after targeted insertion of the GFP2 reporter. (B) FACS
analysis of primary AID positive and AID negative transfectants. (C) Fluctuation analysis of subclones.
doi:10.1371/journal.pgen.1000332.g005
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analyzed by FACS about three weeks after transfection and the
subclones two weeks after subcloning. As the green fluorescence
levels in the main populations varied slightly among the
transfectants, the gates to separate the main population of green
fluorescent cells from cells showing decreased or lost green
fluorescence were adapted accordingly. At least 5000 events falling
into the live cell gate were collected for each primary transfectant
or subclone. Subclones in which more than 50% of the live cell
events fell into the gates for decreased or lost green fluorescence
were excluded from the analysis as they might represent the
expansion of a precursor cell already expressing a mutated GFP2
transgene at the time of subcloning.
GFP Gene Sequencing
To minimize PCR-introduced mutations, Pfu Ultra hotstart
polymerase (Stratagene) was used for the amplifications of the GFP
open reading frames prior to sequencing. Sequencing and
sequence analysis were performed as previously described [19].
RT-PCR
RT-PCR was performed as previously described [2]. Primer
pairs used for amplification of the GFP and elongation factor 1a
transcripts are shown in Table S2.
Supporting Information
Figure S1 (A) Targeting strategy of the GFP2 reporter into four
different loci on chromosome 15. (B) Targeting strategy of the
GFP2 reporter into the A-MYB, RAD52, BACH2, and BCL6 loci.
The targeting strategies used for the insertions into the AID and
the RMD1 loci were described previously [2,29].
Found at: doi:10.1371/journal.pgen.1000332.s001 (1.87 MB EPS)
Figure S2 Comparison of GFP gene expression levels analyzed
by semi-quantitative RT-PCR of primary transfectants belonging
to the stepwise deletions series of the ‘W’ fragment.
Found at: doi:10.1371/journal.pgen.1000332.s002 (2.27 MB EPS)
Table S1 Green fluorescence decrease in individual primary
transfectants. (A) GFP2 reporter in the vicinity of the IgL locus. (B)
GFP2 reporter in non-Ig loci.
Found at: doi:10.1371/journal.pgen.1000332.s003 (0.11 MB
XLS)
Table S2 List of primers.
Found at: doi:10.1371/journal.pgen.1000332.s004 (0.12 MB
DOC)
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